Charles Schwab Investment Management Inc Acumen Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 126,747 shares of ABOS stock, worth $157,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126,747
Previous 108,743
16.56%
Holding current value
$157,166
Previous $269,000
18.96%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ABOS
# of Institutions
81Shares Held
40.6MCall Options Held
28.6KPut Options Held
76.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$18.5 Million0.42% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.24 Million2.23% of portfolio
-
Franklin Resources Inc San Mateo, CA3.27MShares$4.06 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.68 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.41 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $50.2M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...